Inhibitor Therapeutics, Inc. (OTCMKTS:INTI – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 100 shares, a drop of 99.6% from the February 29th total of 24,800 shares. Based on an average daily volume of 10,800 shares, the days-to-cover ratio is currently 0.0 days.
Inhibitor Therapeutics Stock Performance
Shares of OTCMKTS INTI remained flat at $0.07 during midday trading on Thursday. Inhibitor Therapeutics has a 12-month low of $0.01 and a 12-month high of $0.30. The firm has a 50-day moving average price of $0.08 and a two-hundred day moving average price of $0.08.
Inhibitor Therapeutics Company Profile
See Also
- Five stocks we like better than Inhibitor Therapeutics
- What is the FTSE 100 index?
- 3 Value Stocks Too Small For Buffett’s Portfolio
- CD Calculator: Certificate of Deposit Calculator
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Inhibitor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inhibitor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.